Thrombopoietin mimetics vs placebo
Mortality during study · Adult patients with myelodysplastic syndromes and thrombocytopenia
Thrombopoietin mimetics showed no clear difference in mortality during study compared with placebo (low certainty).
1 finding from 1 review
- Thrombopoietin mimetics for patients with myelodysplastic syndromes 2017 · Cochrane Headline outcomes onlyRR 0.97 [0.73, 1.27]6 studies · 746 participantsLow